Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
We share a recent sponsored article in Politico and reports from Danish news outlets.
We share a report about a 24-year-old with hemophilia B who recently received gene therapy in California.
We share a report about a 32-year-old with hemophilia B who recently received gene therapy at Harvard-affiliated Brigham and …
Antti Kourula, CSL Behring’s Vice President of Commercial Development for Hematology, recently traveled to the Central Asian …
We share reports about a 57-year-old and 63-year-old with hemophilia B who recently received gene therapy.
Better care can begin with bleeding assessment tools and a doctor who understands how bleeding disorders impact women’s healt…
CSL joins with the global bleeding disorders community – including women and girls – to support empowerment and access to tre…
Did you know? Kids who have bleeding disorders play baseball. A longtime coach for CSL Behring’s Gettin’ In the Game Junior N…
Hemophilia A and B can have similar symptoms, but their underlying causes and potential treatments differ.
The JNC, celebrating its 22nd year, hosts children and teens in the bleeding disorders community for a weekend full of sports…
Tim Grams, father of four, dove into swimming as a young person and today stays active despite Hemophilia A.
CSL recognizes patients around the globe who live with bleeding disorders such as hemophilia. Continued innovation and improv…
Americas
Asia Pacific
Middle East
Europe
